Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
First-line tuberculosis treatment with double-dose rifampicin is well tolerated.
Maug AKJ, Hossain MA, Gumusboga M, Decroo T, Mulders W, Braet S, Buyze J, Arango D, Schurmans C, Herssens N, Demeulenaere T, Lynen L, de Jong BC, Van Deun A. Maug AKJ, et al. Among authors: mulders w. Int J Tuberc Lung Dis. 2020 May 1;24(5):499-505. doi: 10.5588/ijtld.19.0063. Int J Tuberc Lung Dis. 2020. PMID: 32398199 Clinical Trial.
Deciphering the growth behaviour of Mycobacterium africanum.
Gehre F, Otu J, DeRiemer K, de Sessions PF, Hibberd ML, Mulders W, Corrah T, de Jong BC, Antonio M. Gehre F, et al. Among authors: mulders w. PLoS Negl Trop Dis. 2013 May 16;7(5):e2220. doi: 10.1371/journal.pntd.0002220. Print 2013. PLoS Negl Trop Dis. 2013. PMID: 23696911 Free PMC article.
The perceived impact of isoniazid resistance on outcome of first-line rifampicin-throughout regimens is largely due to missed rifampicin resistance.
Van Deun A, Decroo T, Kya Jai Maug A, Hossain MA, Gumusboga M, Mulders W, Ortuño-Gutiérrez N, Lynen L, de Jong BC, Rieder HL. Van Deun A, et al. Among authors: mulders w. PLoS One. 2020 May 18;15(5):e0233500. doi: 10.1371/journal.pone.0233500. eCollection 2020. PLoS One. 2020. PMID: 32421749 Free PMC article.
Case Report: Dynamics of Acquired Fluoroquinolone Resistance under Standardized Short-Course Treatment of Multidrug-Resistant Tuberculosis.
Ngabonziza JCS, Van Deun A, Migambi P, Niyigena EB, Dusabe T, Habimana YM, Ushizimpumu B, Mulders W, Decroo T, Affolabi D, Supply P, de Jong BC, Rigouts L. Ngabonziza JCS, et al. Among authors: mulders w. Am J Trop Med Hyg. 2020 Oct;103(4):1443-1446. doi: 10.4269/ajtmh.20-0201. Am J Trop Med Hyg. 2020. PMID: 32618257 Free PMC article.
Effectiveness of GenoType MTBDRsl in excluding TB drug resistance in a clinical trial.
Ejo M, Van Deun A, Nunn A, Meredith S, Ahmed S, Dalai D, Tumenbayar O, Tsogt B, Dat PT, Ha DTM, Hang PT, Kokebu D, Teferi M, Mebrahtu T, Ngubane N, Moodliar R, Duckworth L, Conradie F, Enduwamahoro E, Keysers J, De Rijk P, Mulders W, Diro E, Rigouts L, de Jong BC, Torrea G. Ejo M, et al. Among authors: mulders w. Int J Tuberc Lung Dis. 2021 Oct 1;25(10):839-845. doi: 10.5588/ijtld.21.0212. Int J Tuberc Lung Dis. 2021. PMID: 34615581 Free PMC article.
Multidrug-resistant tuberculosis control in Rwanda overcomes a successful clone that causes most disease over a quarter century.
Ngabonziza JCS, Rigouts L, Torrea G, Decroo T, Kamanzi E, Lempens P, Rucogoza A, Habimana YM, Laenen L, Niyigena BE, Uwizeye C, Ushizimpumu B, Mulders W, Ivan E, Tzfadia O, Muvunyi CM, Migambi P, Andre E, Mazarati JB, Affolabi D, Umubyeyi AN, Nsanzimana S, Portaels F, Gasana M, de Jong BC, Meehan CJ. Ngabonziza JCS, et al. Among authors: mulders w. J Clin Tuberc Other Mycobact Dis. 2022 Jan 24;27:100299. doi: 10.1016/j.jctube.2022.100299. eCollection 2022 May. J Clin Tuberc Other Mycobact Dis. 2022. PMID: 35146133 Free PMC article. Review.
94 results